VAERS Explorer
Back to explore

Report #2870319

Received Nov 3, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
IL
Recovered
Unknown
Vaccinated
Aug 26, 2024
Onset
Aug 26, 2024
Days to onset
0
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
MENBMENINGOCOCCAL B (BEXSERO)NOVARTIS VACCINES AND DIAGNOSTICS2Z39XM—
MENBMENINGOCOCCAL B (BEXSERO)NOVARTIS VACCINES AND DIAGNOSTICS1X4BK3—

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

Inappropriate age at vaccine administration; Inappropriate age at vaccine administration; This non-serious case was reported by a consumer via call center representative and described the occurrence of inappropriate age at vaccine administration in a female patient who received Men B NVS (Bexsero) (batch number Z39XM, expiry date 31-OCT-2026) for prophylaxis. Co-suspect products included Men B NVS (Bexsero) (batch number X4BK3, expiry date 30-SEP-2026) for prophylaxis. The patient's past medical history included splenectomy and pancreatectomy. On 25-OCT-2025, the patient received the 2nd dose of Bexsero. On 26-AUG-2024, the patient received the 1st dose of Bexsero. On 26-AUG-2024, not applicable after receiving Bexsero and an unknown time after receiving Bexsero, the patient experienced inappropriate age at vaccine administration (Verbatim: Inappropriate age at vaccine administration). On 25-OCT-2025, the patient experienced inappropriate age at vaccine administration (Verbatim: Inappropriate age at vaccine administration). The outcome of the inappropriate age at vaccine administration and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 16-OCT-2025 The reporter stated that she had both a splenectomy and pancreatectomy at a hospital (pre-existing Bexsero) and post operation, the hospital ordered Bexsero for her to receive and provided her with a vaccine schedule for three doses The patient did receive two doses of Bexsero, the first at the hospital, the second at her Primary Care Physician's office. The patient reported that she knew it was for young people, and not old people like her, but was trying to locate someone to provide her the third dose. The patient got frustrated and disconnected the call before I could ask for further demographics, consent, or any further information about the product administration.

Medical history

Medical History/Concurrent Conditions: Pancreatectomy; Splenectomy